Johanna Friedl Naderer Vir Biotechnology, Inc. (VIR) insider trading activity

Johanna Friedl Naderer is EVP & Chief Operating Officer of Vir Biotechnology, Inc.. Currently has a direct ownership of 148,518 shares of VIR, which is worth approximately $1.1 Million. The most recent transaction as insider was on Mar 03, 2023, when has been sold 1,482 shares (Common Stock) at a price of $22.82 per share, resulting in proceeds of $33,819. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 149K

0% 3M change

0% 12M change

Total Value Held $1.1 Million

Johanna Friedl-Naderer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 03 2023	SELL Open market or private sale	$33,819 $22.82 p/Share	1,482 Reduced 0.99%	148,518 Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	60,000 Added 28.57%	150,000 Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	90,000 Added 50.0%	90,000 Common Stock

Also insider at

DYN

Dyne Therapeutics, Inc. Healthcare

Chief Commercial Officer